Literature DB >> 22734033

Germline mutation in MSH6 associated with multiple malignant neoplasms in a patient With Muir-Torre syndrome.

Zarry Tavakkol1, Jesse J Keller, Paul S Furmanczyk, Robin L Bennett, Andy J Chien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734033     DOI: 10.1200/JCO.2011.41.5562

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  The role of immunohistochemistry in the Muir-Torre Syndrome.

Authors:  Cláudia Marina Puga Barbosa Oliveira; Jullyene Gomes de Campos; Maiko Ramacos Maia; Larissa Eva dos Santos Lobo; Fábio Francesconi do Valle
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

2.  Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

Authors:  Kelly L Stratton; Shaheen Alanee; Emily A Glogowski; Kasmintan A Schrader; Rohini Rau-Murthy; Robert Klein; Paul Russo; Jonathan Coleman; Kenneth Offit
Journal:  Urol Oncol       Date:  2015-12-23       Impact factor: 3.498

3.  [Sebaceous gland tumor with a rare gene mutation within a tumor syndrome: Muir-Torre syndrome].

Authors:  E Voigt; F Sommer; K D Geiger; L E Pillunat
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

4.  Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in MSH6 and Molecular Analysis: Report of a Case and Review of the Literature.

Authors:  Yu Yang; Shweta Dhar; Jennifer Taylor; Bhuvaneswari Krishnan
Journal:  J Kidney Cancer VHL       Date:  2021-04-21

5.  Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.

Authors:  Aoife J McCarthy; Jose-Mario Capo-Chichi; Tara Spence; Sylvie Grenier; Tracy Stockley; Suzanne Kamel-Reid; Stefano Serra; Peter Sabatini; Runjan Chetty
Journal:  J Pathol Clin Res       Date:  2018-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.